The association between urinary glucose excretion and the water or caffein intake in subjects with Ipragliflozin in patients with type 2 diabetes mellitus

The association between urinary glucose excretion and the water or caffein intake in subjects with Ipragliflozin in patients with type 2 diabetes mellitus - Urinary glucose excretion and the water or caffein intake on Ipragliflozin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014611

Enrollment

Registered

2014-08-10

Start date

2015-06-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Ipragliflozin lowdose-watter lowdose-caffein Ipragliflozin highdose-watter lowdose-caffein Ipragliflozin lowdose-watter highdose-caffein

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HbA1c<7.0%

Exclusion criteria

Exclusion criteria: BNP>40 pg/ml eGFR<60ml/min medication for diabtes

Design outcomes

Primary

Measure	Time frame
urinary glucose excretion	—

Countries

Japan

Contacts

Public ContactMuhei Tanaka

Kyoto Prefectural University of Medicine, Graduate School of Medical Science Department of Endocrinology and Metabolism

muhei-t@koto.kpu-m.ac.jp+81-75-251-5505

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026